Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cancers of the blood using selected glycomimetic compounds

Treatment of cancers of the blood using selected glycomimetic compounds

US Patent 8518896 · Granted Aug 27, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

E-selectin antagonist compounds, compositions, and methods of use2024
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists2024
Galectin-3 inhibiting c-glycosides2024
Heterobifunctional inhibitors of E-selectin and galectin-32023
Highly potent multimeric e-selectin antagonists2023
Methods of mobilizing marrow infiltrating lymphocytes and uses thereof2023
Heterobifunctional inhibitors of E-selectin and galectin-32023
Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXC2022
E-selectin antagonist compounds, compositions, and methods of use2022
Methods for the treatment and/or prevention of cardiovascular disease by inhibit2022
Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists2021
Highly potent multimeric e-selectin antagonists2021